v3.26.1
Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Preferred stock
Series A Preferred Stock
Preferred stock
Series B Preferred Stock
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Preferred stock, beginning balance (in shares) at Dec. 31, 2024       120,790.402 437,927        
Beginning balance at Dec. 31, 2024 $ (6,802)     $ 0 $ 0 $ 3 $ 689,887 $ (692,071) $ (4,621)
Common stock, beginning balance (in shares) at Dec. 31, 2024           25,767,369      
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock upon exercise of options (in shares)           55,690      
Issuance of common stock upon exercise of options 183           183    
Issuance of common stock upon vesting of restricted stock units (in shares)           113,042      
Stock-based compensation expense 2,508           2,508    
Currency translation adjustment 32               32
Net loss (17,710)             (17,710)  
Preferred stock, ending balance (in shares) at Mar. 31, 2025       120,790.402 437,927        
Ending balance at Mar. 31, 2025 $ (21,789)     $ 0 $ 0 $ 3 692,578 (709,781) (4,589)
Common stock, ending balance (in shares) at Mar. 31, 2025           25,936,101      
Preferred stock, beginning balance (in shares) at Dec. 31, 2025 0 120,790.402 437,927 120,790.402 437,927        
Beginning balance at Dec. 31, 2025 $ (126,240)     $ 0 $ 0 $ 3 700,706 (822,373) (4,576)
Common stock, beginning balance (in shares) at Dec. 31, 2025 26,011,106         26,011,106      
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock upon exercise of options (in shares)           93,632      
Issuance of common stock upon exercise of options $ 304           304    
Issuance of common stock upon vesting of restricted stock units (in shares)           169,278      
Issuance of common stock through at the market offering, net of commissions and expenses (in shares)           2,270,712      
Issuance of common stock through at the market offering, net of commissions and expenses 14,584           14,584    
Stock-based compensation expense 2,423           2,423    
Currency translation adjustment (7)               (7)
Net loss $ (39,182)             (39,182)  
Preferred stock, ending balance (in shares) at Mar. 31, 2026 0 120,790.402 437,927 120,790.402 437,927        
Ending balance at Mar. 31, 2026 $ (148,118)     $ 0 $ 0 $ 3 $ 718,017 $ (861,555) $ (4,583)
Common stock, ending balance (in shares) at Mar. 31, 2026 28,544,728         28,544,728